The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

Principal of GMC Rajouri, Dr Amarjeet Singh Bhatia, told TNIE that the doctors at the hospital are now planning to reduce the Atropine doses for the patients. "All 11 patients undergoing treatment ...

SRINAGAR: In a major breakthrough, the doctors at GMC Rajouri have administered atropine to treat 11 patients who fell ill from a mysterious illness in Badhal village of J&K’s Rajouri.

Treated with atropine, the patients showed unexpected recovery, and doctors are awaiting details on the toxin to ensure long-term protection. No new cases emerged in the past four days.